{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:40:43Z","timestamp":1775652043658,"version":"3.50.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Peptides"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.regpep.2014.05.001","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T23:33:25Z","timestamp":1399678405000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice"],"prefix":"10.1016","volume":"190-191","author":[{"given":"Vladimer","family":"Darsalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Olverling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Nathanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5ke","family":"Sj\u00f6holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Patrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.regpep.2014.05.001_bb0005","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s00415-009-5143-1","article-title":"Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives","volume":"256","author":"Sander","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/01.WNL.0000101461.61501.65","article-title":"Burden of first-ever ischemic stroke in the oldest old: evidence from a population-based study","volume":"62","author":"Marini","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.regpep.2014.05.001_bb0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1474-4422(12)70005-4","article-title":"Diabetes, hyperglycaemia, and acute ischaemic stroke","volume":"11","author":"Luitse","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.regpep.2004.06.007","article-title":"What do we know about the secretion and degradation of incretin hormones?","volume":"128","author":"Deacon","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.regpep.2014.05.001_bb0025","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","article-title":"Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine","volume":"140","author":"Hansen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2014.05.001_bb0030","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/endo.140.4.6643","article-title":"Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion","volume":"140","author":"Rocca","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.regpep.2014.05.001_bb0035","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.regpep.2014.05.001_bb0040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.regpep.2014.05.001_bb0045","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/s-2004-826178","article-title":"GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes","volume":"36","author":"Ahren","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.regpep.2014.05.001_bb0050","first-page":"113","article-title":"Incretin mimetics and DPP-4 inhibitors: new approach to treatment of type 2 diabetes mellitus","volume":"18","author":"Siddiqui","year":"2009","journal-title":"Mymensingh Med J"},{"key":"10.1016\/j.regpep.2014.05.001_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pharmthera.2009.06.002","article-title":"Novel therapeutics for type 2 diabetes: incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors","volume":"124","author":"Verspohl","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.regpep.2014.05.001_bb0060","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.bcp.2011.11.028","article-title":"DPP-4 inhibitors in the treatment of type 2 diabetes","volume":"83","author":"Duez","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0065","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.clinthera.2010.06.004","article-title":"Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects","volume":"32","author":"Sarashina","year":"2010","journal-title":"Clin Ther"},{"key":"10.1016\/j.regpep.2014.05.001_bb0070","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1517\/13543780903463862","article-title":"Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes","volume":"19","author":"Deacon","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.regpep.2014.05.001_bb0075","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/2042018812449406","article-title":"Linagliptin for type 2 diabetes mellitus: a review of the pivotal clinical trials","volume":"3","author":"McGill","year":"2012","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/j.regpep.2014.05.001_bb0080","doi-asserted-by":"crossref","first-page":"T31","DOI":"10.1530\/JOE-13-0221","article-title":"Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases","volume":"221","author":"Holscher","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0085","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1476-5381.2009.00486.x","article-title":"Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection","volume":"159","author":"Harkavyi","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0090","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1476-5381.2012.01971.x","article-title":"Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders","volume":"166","author":"Salcedo","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0095","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1185\/03007995.2010.549466","article-title":"Neuroprotective properties of GLP-1: theoretical and practical applications","volume":"27","author":"Holst","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.regpep.2014.05.001_bb0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(13)70125-6","article-title":"Diabetes drugs and neurological disorders: new views and therapeutic possibilities","volume":"2","author":"Patrone","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.regpep.2014.05.001_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.ijo.0802206","article-title":"Entry of exendin-4 into brain is rapid but may be limited at high doses","volume":"27","author":"Kastin","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.regpep.2014.05.001_bb0115","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2337\/db12-0988","article-title":"The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride","volume":"62","author":"Darsalia","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2014.05.001_bb0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/CS20110374","article-title":"Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats","volume":"122","author":"Darsalia","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.regpep.2014.05.001_bb0125","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/jnr.22596","article-title":"Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia","volume":"89","author":"Lee","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.regpep.2014.05.001_bb0130","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/jcbfm.2011.51","article-title":"Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia","volume":"31","author":"Teramoto","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.regpep.2014.05.001_bb0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrcardio.2011.211","article-title":"The effect of glucagon-like peptide 1 on cardiovascular risk","volume":"9","author":"Sivertsen","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0140","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/jcbfm.2012.133","article-title":"Liraglutide, a long-acting GLP-1 mimetic, and its metabolite attenuate inflammation after intracerebral hemorrhage","volume":"32","author":"Hou","year":"2012","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.regpep.2014.05.001_bb0145","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejphar.2012.12.012","article-title":"The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain","volume":"700","author":"Parthsarathy","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.neuron.2011.05.001","article-title":"Adult neurogenesis in the mammalian brain: significant answers and significant questions","volume":"70","author":"Ming","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.regpep.2014.05.001_bb0155","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nm747","article-title":"Neuronal replacement from endogenous precursors in the adult brain after stroke","volume":"8","author":"Arvidsson","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.regpep.2014.05.001_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1073858403252680","article-title":"Injury-induced neurogenesis in the adult mammalian brain","volume":"9","author":"Parent","year":"2003","journal-title":"Neuroscientist"},{"key":"10.1016\/j.regpep.2014.05.001_bb0165","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1161\/STROKEAHA.110.599654","article-title":"Stem cell research in stroke: how far from the clinic?","volume":"42","author":"Lindvall","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.regpep.2014.05.001_bb0170","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jnr.21483","article-title":"Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease","volume":"86","author":"Bertilsson","year":"2008","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.regpep.2014.05.001_bb0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jnr.22565","article-title":"Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain","volume":"89","author":"Hamilton","year":"2011","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.regpep.2014.05.001_bb0180","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2010.10.008","article-title":"The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test","volume":"650","author":"Isacson","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neulet.2010.09.040","article-title":"Chronic treatment of exendin-4 affects cell proliferation and neuroblast differentiation in the adult mouse hippocampal dentate gyrus","volume":"486","author":"Li","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.regpep.2014.05.001_bb0190","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ijo.2012.91","article-title":"Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob\/ob mice","volume":"37","author":"Porter","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.regpep.2014.05.001_bb0195","doi-asserted-by":"crossref","first-page":"e58784","DOI":"10.1371\/journal.pone.0058784","article-title":"Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model","volume":"8","author":"Parthsarathy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.regpep.2014.05.001_bb0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1742-2094-9-44","article-title":"Dipeptidyl peptidase IV, aminopeptidase N and DPIV\/APN-like proteases in cerebral ischemia","volume":"9","author":"Rohnert","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.regpep.2014.05.001_bb0205","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2013.04.015","article-title":"Alogliptin, a dipeptidylpeptidase-4 inhibitor, for patients with diabetes mellitus type 2, induces tolerance to focal cerebral ischemia in non-diabetic, normal mice","volume":"1517","author":"Yang","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.regpep.2014.05.001_bb0210","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.exger.2009.12.004","article-title":"Long-term inhibition of dipeptidyl peptidase-4 in Alzheimer's prone mice","volume":"45","author":"D'Amico","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0215","first-page":"1","article-title":"Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes","volume":"6","author":"Gallwitz","year":"2013","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"10.1016\/j.regpep.2014.05.001_bb0220","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1900\/RDS.2011.8.418","article-title":"GLP-1, the gut\u2013brain, and brain\u2013periphery axes","volume":"8","author":"Cabou","year":"2011","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/j.regpep.2014.05.001_bb0225","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2337\/db12-1794","article-title":"DPP-4 inhibition and neuroprotection: do mechanisms matter?","volume":"62","author":"Shannon","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.regpep.2014.05.001_bb0230","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.regpep.2014.05.001_bb0235","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc07-0228","article-title":"Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action","volume":"30","author":"Drucker","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.regpep.2014.05.001_bb0240","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/00004647-199607000-00010","article-title":"Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion","volume":"16","author":"Hara","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.regpep.2014.05.001_bb0245","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jnr.22803","article-title":"Pituitary adenylate cyclase-activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitate","volume":"90","author":"Mansouri","year":"2012","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.regpep.2014.05.001_bb0250","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/jnc.12396","article-title":"GalR3 activation promotes adult neural stem cell survival in response to a diabetic milieu","volume":"127","author":"Mansouri","year":"2013","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.regpep.2014.05.001_bb0255","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/jnr.22803","article-title":"Pituitary adenylate cyclase-activating polypeptide counteracts the impaired adult neural stem cell viability induced by palmitate","volume":"90","author":"Mansouri","year":"2012","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.regpep.2014.05.001_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/jnr.20038","article-title":"PACAP promotes neural stem cell proliferation in adult mouse brain","volume":"76","author":"Mercer","year":"2004","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.regpep.2014.05.001_bb0265","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bbr.2011.08.045","article-title":"Does the endogenous neurogenic response alter behavioral recovery following stroke?","volume":"227","author":"Lagace","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.regpep.2014.05.001_bb0270","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1460-9568.2011.07650.x","article-title":"Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions","volume":"33","author":"Rivera","year":"2011","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.regpep.2014.05.001_bb0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0306-4522(01)00117-8","article-title":"Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia","volume":"105","author":"Zhang","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.regpep.2014.05.001_bb0280","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1073\/pnas.081011098","article-title":"Neurogenesis in dentate subgranular zone and rostral subventricular zone after focal cerebral ischemia in the rat","volume":"98","author":"Jin","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.regpep.2014.05.001_bb0285","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1634\/stemcells.2005-0281","article-title":"Persistent production of neurons from adult brain stem cells during recovery after stroke","volume":"24","author":"Thored","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.regpep.2014.05.001_bb0290","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1523\/JNEUROSCI.1109-04.2004","article-title":"Stroke transiently increases subventricular zone cell division from asymmetric to symmetric and increases neuronal differentiation in the adult rat","volume":"24","author":"Zhang","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.regpep.2014.05.001_bb0295","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1124\/dmd.110.034199","article-title":"The dipeptidyl peptidase-4 inhibitor linagliptin exhibits time- and dose-dependent localization in kidney, liver, and intestine after intravenous dosing: results from high resolution autoradiography in rats","volume":"38","author":"Greischel","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.regpep.2014.05.001_bb0300","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejphar.2011.11.007","article-title":"Effects of acute and chronic administration of GIP analogues on cognition, synaptic plasticity and neurogenesis in mice","volume":"674","author":"Faivre","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.regpep.2014.05.001_bb0305","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1523\/JNEUROSCI.4920-04.2005","article-title":"Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation","volume":"25","author":"Nyberg","year":"2005","journal-title":"J Neurosci"},{"issue":"Suppl. 3","key":"10.1016\/j.regpep.2014.05.001_bb0310","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/S1262-3636(10)70468-7","article-title":"The gut\u2013brain axis: a major glucoregulatory player","volume":"36","author":"Burcelin","year":"2010","journal-title":"Diabetes Metab"}],"container-title":["Regulatory Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011514000445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167011514000445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:18:05Z","timestamp":1759072685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167011514000445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":62,"alternative-id":["S0167011514000445"],"URL":"https:\/\/doi.org\/10.1016\/j.regpep.2014.05.001","relation":{},"ISSN":["0167-0115"],"issn-type":[{"value":"0167-0115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Linagliptin enhances neural stem cell proliferation after stroke in type 2 diabetic mice","name":"articletitle","label":"Article Title"},{"value":"Regulatory Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.regpep.2014.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}